Literature DB >> 18042926

Trend toward noninferiority trials may mean more difficult interpretation of trial results.

Rabiya S Tuma.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18042926     DOI： 10.1093/jnci/djm258

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.

Authors:  Patrick Vavken
Journal:  Clin Orthop Relat Res       Date:  2011-01-19       Impact factor: 4.176

2.  Creative trial design in RA: optimizing patient outcomes.

Authors:  Maya H Buch; Sue Pavitt; Mahesh Parmar; Paul Emery
Journal:  Nat Rev Rheumatol       Date:  2013-02-05       Impact factor: 20.543

Review 3.  A clinician's guide to the assessment and interpretation of noninferiority trials for novel therapies.

Authors:  Simon J W Oczkowski
Journal:  Open Med       Date:  2014-05-06

4.  Noninferior Antibiotics: When Is "Not Bad" "Good Enough"?

Authors:  Mark J DiNubile
Journal:  Open Forum Infect Dis       Date:  2016-05-25       Impact factor: 3.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.